<!DOCTYPE html>
<html lang="en" data-theme="light">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Anti-dyslipidemias | Cardiovascular Pharmacology</title>
    
    <!-- Preconnect for performance -->
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    
    <!-- Google Fonts -->
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&family=Source+Serif+4:opsz,wght@8..60,400;8..60,600&display=swap" rel="stylesheet">
    
    <!-- Main Stylesheet -->
    <link rel="stylesheet" href="../styles/main.css">
    
    <!-- MathJax Configuration -->
    <script>
    MathJax = {
        tex: {
            inlineMath: [['$', '$'], ['\\(', '\\)']],
            displayMath: [['$$', '$$'], ['\\[', '\\]']],
            processEscapes: true
        },
        svg: { fontCache: 'global' }
    };
    </script>
    <script id="MathJax-script" async src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-mml-chtml.js"></script>
</head>
<body>
    <!-- Skip Link -->
    <a href="#main-content" class="skip-link">Skip to main content</a>
    
    <!-- Reading Progress Bar -->
    <div class="reading-progress-container" aria-hidden="true">
        <div class="reading-progress-bar" id="reading-progress"></div>
    </div>

    <!-- Theme Toggle -->
    <button class="theme-toggle" id="theme-toggle" aria-label="Toggle dark mode" title="Toggle dark mode">
        <span class="theme-toggle-icon light-icon">‚òÄÔ∏è</span>
        <span class="theme-toggle-icon dark-icon">üåô</span>
    </button>

    <div class="page-wrapper">
        <!-- Floating Mini-TOC -->
        <aside class="floating-toc" id="floating-toc" aria-label="On this page">
            <div class="floating-toc-header">
                <span class="floating-toc-icon">üìë</span>
                <span>On this page</span>
            </div>
            <nav class="floating-toc-nav">
                <ul class="floating-toc-list">
                    <!-- Populated by JS -->
                </ul>
            </nav>
        </aside>

        <div class="container">
            <article class="document-article" role="main" id="main-content">
                <!-- Top Navigation -->
                <nav class="document-nav" role="navigation" aria-label="Document navigation">
                    <div class="nav-container">
                        <a href="../index.html" class="nav-button nav-button--toc" aria-label="Table of Contents">
                            <span class="nav-icon">üìö</span>
                            <span class="nav-text">Contents</span>
                        </a>
                        
                        <a href="topic-05-coagulation-disorders.html" class="nav-button nav-button--prev" aria-label="Previous section">
                            <span class="nav-icon">‚Üê</span>
                            <span class="nav-text">Coagulation Disorders</span>
                        </a>
                        
                        <div class="document-progress">
                            <div class="progress-indicator">
                                <span class="progress-current">06</span>
                                <span class="progress-separator">/</span>
                                <span class="progress-total">06</span>
                            </div>
                            <div class="progress-bar-container" aria-hidden="true">
                                <div class="progress-bar-fill" style="width: 100%;"></div>
                            </div>
                            <span class="progress-label">Anti-dyslipidemias</span>
                        </div>
                        
                        <a href="../index.html" class="nav-button nav-button--next" aria-label="Return to Index">
                            <span class="nav-text">Finish</span>
                            <span class="nav-icon">‚úì</span>
                        </a>
                    </div>
                </nav>

                <!-- Breadcrumb -->
                <nav class="breadcrumb" aria-label="Breadcrumb">
                    <ol class="breadcrumb-list">
                        <li class="breadcrumb-item"><a href="../index.html">Home</a></li>
                        <li class="breadcrumb-item"><a href="../index.html">Cardiovascular System</a></li>
                        <li class="breadcrumb-item active" aria-current="page">Anti-dyslipidemias</li>
                    </ol>
                </nav>

                <!-- Document Header -->
                <header class="document-header">
                    <div class="header-badge">
                        <span class="badge-icon">üçî</span>
                        <span class="badge-text">Lipid Pharmacology</span>
                    </div>
                    <h1 class="document-title">Anti-dyslipidemias</h1>
                    <div class="title-meta">
                        <span class="meta-item">
                            <span class="meta-icon">üë§</span>
                            <span>By Geoffrey</span>
                        </span>
                        <span class="meta-item">
                            <span class="meta-icon">üìÖ</span>
                            <span>7th November 2024</span>
                        </span>
                    </div>
                </header>

                <!-- Main Content Area -->
                <div class="content-wrapper">
                    
                    <!-- START: introduction -->
                    <section id="introduction" class="content-section">
                        <div class="section-header">
                            <div class="section-number" aria-hidden="true">01</div>
                            <h2 class="section-title">
                                <span class="title-icon">ü©∫</span>
                                Introduction to Dyslipidemia
                            </h2>
                        </div>
                        
                        <div class="content-card">
                            <ul class="enhanced-list">
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">Coronary artery disease is the leading cause of death world wide.</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">CAD is associated with elevation of low density lipoprotein cholesterol (bad cholesterol) and triglycerides.</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">There is reduced amount of high density lipoprotein (good cholesterol).</span>
                                </li>
                            </ul>
                            <p>Other risk factors of CHD are; smoking, obesity, diabetes and hypertension.</p>
                            <p>Cholesterol levels can be raised due to lack of exercise and diet containing high saturated fats.</p>
                            <p>Hyperlipidemias can also result from genetic defects in lipoprotein metabolism.</p>
                        </div>
                    </section>
                    <!-- END: introduction -->

                    <!-- START: classification -->
                    <section id="classification" class="content-section">
                        <div class="section-header">
                            <div class="section-number" aria-hidden="true">02</div>
                            <h2 class="section-title">
                                <span class="title-icon">üìã</span>
                                Anti-dyslipidemia Classification
                            </h2>
                        </div>
                        <div class="content-card">
                            <ol class="enhanced-list">
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">3-hydroxy-3-methylglutaryl Coenzyme A (HMG COA reductase inhibitors) ‚Äì statins</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">Niacin</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">Fibrates - fenofibrates</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">Bile acid squestrants - colestipol</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">Omega-3-fatty acids</span>
                                </li>
                                <li class="list-item">
                                    <span class="list-marker"></span>
                                    <span class="list-content">Cholesterol absorption inhibitors</span>
                                </li>
                            </ol>
                        </div>
                    </section>
                    <!-- END: classification -->

                    <!-- START: statins -->
                    <section id="statins" class="content-section">
                        <div class="section-header">
                            <div class="section-number" aria-hidden="true">03</div>
                            <h2 class="section-title">
                                <span class="title-icon">üíä</span>
                                HMG-COA Reductase Inhibitors (Statins)
                            </h2>
                        </div>
                        <div class="content-card">
                            <ul class="enhanced-list">
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">3-hydroxy-3-methylglutaryl Coenzyme A (HMG COA reductase inhibitors)</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Commonly known as <em>statins</em></span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Reduce LDL-C</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content"><em>First line treatment in patients</em> with atherosclerosis disease</span></li>
                            </ul>

                            <h3 id="statins-benefits">Benefits of HMG-COA Reductace Inhibitors</h3>
                            <ol class="enhanced-list">
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Plaque stabilization</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Inhibition of platelet thrombus formation.</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Improvement of coronary endothelial function</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Anti-inflammatory activity.</span></li>
                            </ol>

                            <h3 id="statins-moa">Mode of Action of HMG-COA</h3>
                            <ul class="enhanced-list">
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Competitive inhibitors of HMG-COA reductase ratelimiting step in cholesterol synthesis.</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">This leads to reduced intracellular supply of cholesterol.</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Reduced intracellular cholesterol supply eventually results to increase in number of cell surface LDL receptors that bind and internalize circulating LDLs.</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Examples; <em>atorvastatin, simvastatin, pitavastatin, rosuvastatin, fluvastatin, lovastatin and pravastatin</em>.</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Also decrease triglyceride levels and increase HDL in some patients.</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">The most potent statins are:- atorvastatin, pitavastatin and rosuvastatin.</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Pharmacokinetics; absorption of statins varies from 30-85%, simvastatin and lovastatin are given in inactive forms. Metabolized in the liver and excreted in feces and bile and some through urine.</span></li>
                            </ul>

                            <h3 id="statins-adverse">Adverse Effects of HMG-CoA</h3>
                            <ol class="enhanced-list">
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Elevated liver enzymes</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Myopathy</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Rhabdomyolysis</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Hepatitis</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Contraindicated in pregnancy-teratogenic</span></li>
                            </ol>
                            <p>Drug interactions; block the action of warfarin leading to accumulation of high levels in the body. Monitor the INR</p>

                            <figure class="content-figure" data-lightbox="true">
                                <div class="figure-image-wrapper">
                                    <img src="../../../../assets/images/image-20251214-bc54991c.jpeg" 
                                         alt="Cosmos Avastatin (Atorvastatin) Tablets Box" 
                                         class="figure-image"
                                         loading="lazy">
                                    <div class="figure-overlay">
                                        <span class="overlay-icon">üîç</span>
                                        <span class="overlay-text">Click to enlarge</span>
                                    </div>
                                </div>
                                <figcaption class="figure-caption">Atorvastatin Tablets 10mg (Film Coated)</figcaption>
                            </figure>
                        </div>
                    </section>
                    <!-- END: statins -->

                    <!-- START: niacin -->
                    <section id="niacin" class="content-section">
                        <div class="section-header">
                            <div class="section-number" aria-hidden="true">04</div>
                            <h2 class="section-title">
                                <span class="title-icon">üíä</span>
                                Niacin (Nicotinic acid)
                            </h2>
                        </div>
                        <div class="content-card">
                            <ul class="enhanced-list">
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Reduce LDL-C in 10-20% and is the most effective in increasing HDL-C.</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Also lowers triglycerides 20-35%.</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content"><em>Used in combination with statins</em></span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content"><strong>M.O.A.</strong> - inhibit lipolysis in adipose tissue leading to reduced production of free fatty acids.</span></li>
                            </ul>
                            <p>The liver uses free fatty acids to produce triglycerides which later are converted by the liver to VLDL-C consequently, this leads to decreased LDL-C plasma concentrations.</p>
                            
                            <ul class="enhanced-list">
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Uses; used to treat familial hyperlipidemias and other hypercholestrolemia with combination with other agents.</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Pharmacokinetics; niacin is taken orally, converted in the body to nicotinamide. Excreted in urine</span></li>
                            </ul>

                            <aside class="callout callout--warning" role="alert">
                                <div class="callout-header">
                                    <span class="callout-icon">‚ö†Ô∏è</span>
                                    <span class="callout-title">Side Effects</span>
                                </div>
                                <div class="callout-content">
                                    <p><em>Side effects:</em> cutaneous flush, pruritus, nausea and vomiting, inhibit tubular secretion of uric acid this can predispose to hyperuricemia and gout, glucose intolerance and hepatotoxicity.</p>
                                </div>
                            </aside>
                        </div>
                    </section>
                    <!-- END: niacin -->

                    <!-- START: fibrates -->
                    <section id="fibrates" class="content-section">
                        <div class="section-header">
                            <div class="section-number" aria-hidden="true">05</div>
                            <h2 class="section-title">
                                <span class="title-icon">üíä</span>
                                Fibrates
                            </h2>
                        </div>
                        <div class="content-card">
                            <h3 id="fenofibrate-gemfibrozil">Fenofibrate and gemfibrozil</h3>
                            <p>Derivatives of fibric acid</p>
                            <ul class="enhanced-list">
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Lowers triglycerides and increase HDL.</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">M.O.A;- bind peroxisome proliferator-activated receptors leading to decreased triglyceride concentrations through increased expression of lipoprotein lipase and reduced apolipoprotein CII concentrations.</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Fenofibrate is more active in lowering triglycerides than gemfibrozil.</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Uses; used to treat hypertriglyceridemias and type III hyperlipidemia.</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Pharmacokinetics;- given orally, plasma bound and distributed widely. Fenofibrate given as a prodrug, metabolized in liver and excreted in urine as glucuronide conjugates.</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Side effects;- GIT disturbances, predispose to gallstones, myositis, myopathy, rhabdomyolysis, not used in renal dysfunction and hepatic dysfunction.</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Drug interactions;- do not use gemfibrozil and simvastatin together, fibrates increase effects of warfarin.</span></li>
                            </ul>
                        </div>
                    </section>
                    <!-- END: fibrates -->

                    <!-- START: bile-acid-resins -->
                    <section id="bile-acid-resins" class="content-section">
                        <div class="section-header">
                            <div class="section-number" aria-hidden="true">06</div>
                            <h2 class="section-title">
                                <span class="title-icon">üß¨</span>
                                Bile acid-Binding Resins
                            </h2>
                        </div>
                        <div class="content-card">
                            <ul class="enhanced-list">
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Lower LDL-cholesterol though less effective than statins.</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">Cholestyramine, colestipol, colesevelam</span></li>
                                <li class="list-item"><span class="list-marker"></span><span class="list-content">M.O.A; bind negatively charged bile acids and bile salts in the small intestine leading to excretion in feces hence reduced bile acid concentration. This leads to hepatocytes converting cholesterol to bile acids.</span></li>
                            </ul>
                            <p>uses; treatment of type IIA and type IIB hyperlipidemias. Used in combination with diet or niacin. Colesevelam can used to lower blood sugar in type 2 DM, cholestyramine is used to reduce pruritus in biliary stasis.</p>
                            <p>Pharmacokinetics; water insoluble, given orally, retained in the lumen not reabsorbed due to its large molecules. Excreted in feces.</p>
                            <p>Adverse effects; nausea, constipation, flatulence, impair fatsoluble vitamins,</p>
                            <p>Drug interactions; interfere with absorption of warfarin, digoxin and thyroid hormone.</p>
                        </div>
                    </section>
                    <!-- END: bile-acid-resins -->

                    <!-- START: absorption-inhibitors -->
                    <section id="absorption-inhibitors" class="content-section">
                        <div class="section-header">
                            <div class="section-number" aria-hidden="true">07</div>
                            <h2 class="section-title">
                                <span class="title-icon">üõë</span>
                                Cholesterol Absorption Inhibitor
                            </h2>
                        </div>
                        <div class="content-card">
                            <h3 id="ezetimibe">Ezetimibe</h3>
                            <p>Selectively inhibit absorption of dietary and biliary cholesterol from the small intestine.</p>
                            <p>This leads to decreased delivery of cholesterol from the small intestine to the liver.</p>
                            <p>The end results in reduction of hepatic cholesterol stores which leads to hepatic clearance of cholesterol from the blood.</p>
                            <p>Metabolized in the small intestine and the liver.</p>
                            <p>Excreted in urine and bile.</p>
                            <p>Lowers LDL-C hence used as adjunct treatment with statins.</p>
                        </div>
                    </section>
                    <!-- END: absorption-inhibitors -->

                    <!-- START: omega-3 -->
                    <section id="omega-3" class="content-section">
                        <div class="section-header">
                            <div class="section-number" aria-hidden="true">08</div>
                            <h2 class="section-title">
                                <span class="title-icon">üêü</span>
                                Omega-3-Fatty Acids
                            </h2>
                        </div>
                        <div class="content-card">
                            <p>Omega-3-polyunsaturated fatty acids are used to lower triglycerides.</p>
                            <p><em>Inhibit VLDL and triglycerides synthesis in the liver.</em></p>
                            <p>Icosapent are capsules for fish oil suppliments.</p>
                            <p>Side effects: GI disturbances, fishy after taste.</p>
                            <p>Drug interactions: increased risk of bleeding when used concomitantly with anticoagulants.</p>
                        </div>
                    </section>
                    <!-- END: omega-3 -->

                    <!-- START: revision -->
                    <section id="revision" class="content-section">
                        <div class="section-header">
                            <div class="section-number" aria-hidden="true">09</div>
                            <h2 class="section-title">
                                <span class="title-icon">üìù</span>
                                Revision
                            </h2>
                        </div>
                        <div class="content-card">
                            <div class="collapsible-section">
                                <details class="collapsible-section">
                                    <summary class="collapsible-trigger">
                                        <span class="trigger-icon">‚ùì</span>
                                        <span class="trigger-text">1. Which of the following is the common side effect of antihyperlipidemic drug therapy?</span>
                                    </summary>
                                    <div class="collapsible-content">
                                        <p>A. Neurological problems</p>
                                        <p>B. Heart palpitations</p>
                                        <p>C. Migraine headache</p>
                                        <p><strong>D. Gastrointestinal disturbances</strong></p>
                                    </div>
                                </details>
                            </div>

                            <div class="collapsible-section">
                                <details class="collapsible-section">
                                    <summary class="collapsible-trigger">
                                        <span class="trigger-icon">‚ùì</span>
                                        <span class="trigger-text">2. Which of the following population of patients are likely to develop myalgia or myopathy with use of statins?</span>
                                    </summary>
                                    <div class="collapsible-content">
                                        <p>A. Patients with gout</p>
                                        <p>B. Patients with DM</p>
                                        <p><strong>C. Patients with renal insufficiency</strong></p>
                                        <p>D. Patients taking warfarin.</p>
                                    </div>
                                </details>
                            </div>
                        </div>
                    </section>
                    <!-- END: revision -->

                    <!-- Key Points Section -->
                    <aside class="key-points-section" role="region" aria-labelledby="key-points-title">
                        <div class="key-points-wrapper">
                            <div class="key-points-header">
                                <span class="key-points-icon">‚≠ê</span>
                                <h3 id="key-points-title" class="key-points-title">Key Points</h3>
                            </div>
                            <ul class="key-points-list">
                                <li class="key-point-item">
                                    <span class="point-marker">‚úì</span>
                                    <p><strong>Coronary artery disease is the leading cause of death world wide.</strong></p>
                                </li>
                                <li class="key-point-item">
                                    <span class="point-marker">‚úì</span>
                                    <p><strong>HMG-COA Reductase Inhibitors (statins) are First line treatment in patients with atherosclerosis disease.</strong></p>
                                </li>
                                <li class="key-point-item">
                                    <span class="point-marker">‚úì</span>
                                    <p><strong>Niacin Reduce LDL-C in 10-20% and is the most effective in increasing HDL-C.</strong></p>
                                </li>
                                <li class="key-point-item">
                                    <span class="point-marker">‚úì</span>
                                    <p><strong>Fibrates lowers triglycerides and increase HDL.</strong></p>
                                </li>
                                <li class="key-point-item">
                                    <span class="point-marker">‚úì</span>
                                    <p><strong>Ezetimibe Selectively inhibit absorption of dietary and biliary cholesterol from the small intestine.</strong></p>
                                </li>
                            </ul>
                        </div>
                    </aside>

                </div>

                <!-- Bottom Navigation -->
                <nav class="document-nav document-nav--bottom" role="navigation" aria-label="Document navigation">
                    <div class="nav-container">
                        <a href="topic-05-coagulation-disorders.html" class="nav-button nav-button--prev nav-button--large">
                            <span class="nav-icon">‚Üê</span>
                            <div class="nav-content">
                                <span class="nav-label">Previous</span>
                                <span class="nav-title">Coagulation Disorders</span>
                            </div>
                        </a>
                        
                        <a href="../index.html" class="nav-button nav-button--toc">
                            <span class="nav-icon">üìö</span>
                            <span class="nav-text">All Topics</span>
                        </a>
                        
                        <a href="../index.html" class="nav-button nav-button--next nav-button--large">
                            <div class="nav-content">
                                <span class="nav-label">Finish</span>
                                <span class="nav-title">Return to Index</span>
                            </div>
                            <span class="nav-icon">‚úì</span>
                        </a>
                    </div>
                </nav>
            </article>
        </div>
    </div>

    <!-- Lightbox Modal -->
    <div class="lightbox-modal" id="lightbox-modal" role="dialog" aria-modal="true" aria-label="Image viewer" hidden>
        <div class="lightbox-backdrop"></div>
        <div class="lightbox-content">
            <button class="lightbox-close" aria-label="Close image viewer">√ó</button>
            <img class="lightbox-image" src="" alt="">
            <p class="lightbox-caption"></p>
        </div>
    </div>

    <!-- Scripts -->
    <script src="../js/theme.js"></script>
    <script src="../js/navigation.js"></script>
    <script src="../js/interactions.js"></script>
</body>
</html>